[{"data":1,"prerenderedAt":227},["ShallowReactive",2],{"drug-chlordiazepoxide":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":51,"contraindications":116,"warnings":144,"renal":145,"monitoring":146,"interactions":147,"review":148,"examples":151,"atc":169,"iran":171,"links":187,"populations":204,"usApproval":222},"chlordiazepoxide",1,{"fa":7,"en":8},"کلردیازپوکساید","Chlordiazepoxide","nervous-system",{"fa":11,"en":12},"بنزودیازپین","Benzodiazepine",[14],{"name":15,"market":16},"Librium","US",[18,19,7],"librium","لیبریوم",[21,35,43],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"cap-5","capsule","oral","5 mg capsule",{"amount":27,"unit":28,"perUnit":23,"scored":29},5,"mg",false,[16],[32],{"source":33,"section":34},"fda-chlordiazepoxide","How Supplied",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"cap-10","10 mg capsule",{"amount":39,"unit":28,"perUnit":23,"scored":29},10,[16],[42],{"source":33,"section":34},{"id":44,"form":23,"route":24,"label":45,"concentration":46,"markets":48,"refs":49},"cap-25","25 mg capsule",{"amount":47,"unit":28,"perUnit":23,"scored":29},25,[16],[50],{"source":33,"section":34},[52,68,79,96],{"id":53,"disease":54,"label":55,"population":58,"type":62,"unit":28,"dose":63,"refs":65},"mild","anxiety",{"fa":56,"en":57},"اضطراب خفیف تا متوسط — ۵ یا ۱۰ mg سه یا چهار بار","Mild–moderate anxiety — 5 or 10 mg three or four times daily",{"minAge":59},{"value":60,"unit":61},18,"year","fixed",{"perDose":27,"perDoseMax":39,"dosesPerDay":64},3,[66],{"source":33,"section":67},"Dosage and Administration",{"id":69,"disease":54,"label":70,"population":73,"type":62,"unit":28,"dose":75,"refs":77},"severe",{"fa":71,"en":72},"اضطراب شدید — ۲۰ یا ۲۵ mg سه یا چهار بار","Severe anxiety — 20 or 25 mg three or four times daily",{"minAge":74},{"value":60,"unit":61},{"perDose":76,"perDoseMax":47,"dosesPerDay":64},20,[78],{"source":33,"section":67},{"id":80,"disease":81,"label":82,"population":85,"type":62,"unit":28,"dose":87,"refs":90,"limits":92},"alcohol","alcohol-withdrawal",{"fa":83,"en":84},"ترک حاد الکل — ۵۰ تا ۱۰۰ mg، تکرار در صورت نیاز","Acute alcohol withdrawal — 50–100 mg, repeated as needed",{"minAge":86},{"value":60,"unit":61},{"perDose":88,"perDoseMax":89,"dosesPerDay":5},50,100,[91],{"source":33,"section":67},{"maxPerDay":93,"refs":94},300,[95],{"source":33,"section":67},{"id":97,"disease":54,"label":98,"population":101,"type":62,"unit":28,"dose":105,"refs":107,"notes":109},"child",{"fa":99,"en":100},"کودکان ۶ سال به بالا — ۵ mg دو تا چهار بار","Children ≥6 y — 5 mg two to four times daily",{"minAge":102,"maxAge":104},{"value":103,"unit":61},6,{"value":60,"unit":61},{"perDose":27,"dosesPerDay":106},2,[108],{"source":33,"section":67},[110],{"text":111,"refs":114},{"fa":112,"en":113},"در برخی تا ۱۰ mg دو یا سه بار.","May increase to 10 mg two or three times daily in some.",[115],{"source":33,"section":67},[117,126,135],{"id":118,"severity":119,"text":120,"refs":123},"ci","block",{"fa":121,"en":122},"حساسیت به دارو.","Hypersensitivity to the drug.",[124],{"source":33,"section":125},"Contraindications",{"id":127,"severity":119,"rule":128,"text":130,"refs":133},"under-6",{"maxAge":129},{"value":103,"unit":61},{"fa":131,"en":132},"زیر ۶ سال توصیه نمی‌شود.","Not recommended under 6 years.",[134],{"source":33,"section":67},{"id":136,"severity":137,"text":138,"refs":141},"boxed","warn",{"fa":139,"en":140},"هشدار جعبه‌ای: مصرف همزمان با اپیوئیدها؛ سوءمصرف و وابستگی؛ ترک با قطع ناگهانی.","Boxed warning: concomitant opioids; abuse and dependence; withdrawal on abrupt stop.",[142],{"source":33,"section":143},"Boxed Warning",[],[],[],[],{"status":149,"reviewer":150,"date":150},"unverified",null,[152,157,160,165],{"regimen":53,"formulation":22,"input":153,"expect":156},{"ageYears":154,"weightKg":155},35,70,{"perDose":27,"upperPerDose":39},{"regimen":69,"formulation":36,"input":158,"expect":159},{"ageYears":154,"weightKg":155},{"perDose":76,"tabletsPerDoseRounded":106},{"regimen":80,"formulation":44,"input":161,"expect":164},{"ageYears":162,"weightKg":163},45,80,{"perDose":88,"tabletsPerDoseRounded":106},{"regimen":97,"formulation":22,"input":166,"expect":168},{"ageYears":167,"weightKg":47},8,{"perDose":27},[170],"N05BA02",{"status":172,"forms":173,"refs":182},"registered",[174,178],{"code":175,"en":176,"fa":177},"00267","CHLORDIAZEPOXIDE 10MG TAB","قرص کلردیازپوکساید ۱۰ میلی‌گرم",{"code":179,"en":180,"fa":181},"00268","CHLORDIAZEPOXIDE 5MG TAB","قرص کلردیازپوکساید ۵ میلی‌گرم",[183],{"source":184,"section":185,"url":186},"darooyab-generic","G-1246\u002FChlordiazepoxide","https:\u002F\u002Fwww.darooyab.ir\u002FG-1246\u002FChlordiazepoxide",[188,192,196,199,202],{"kind":189,"url":190,"label":191},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=084769","ANDA084769",{"kind":193,"url":194,"label":195},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=511264f5-024b-350a-e063-6394a90a51e9","FDA Chlordiazepoxide",{"kind":197,"url":198,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682078.html",{"kind":200,"url":201,"label":170},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=N05BA02",{"kind":203,"url":186,"label":8},"darooyab",{"pregnancy":205,"pediatric":214},{"level":206,"text":207,"quote":210,"refs":211},"caution",{"fa":208,"en":209},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Advise pregnant females that use of chlordiazepoxide HCl late in pregnancy can result in sedation (respiratory depression, lethargy, hypotonia) and\u002For withdrawal symptoms (hyperreflexia, irritability, restlessness, tremors, inconsolable crying, and feeding difficulties) in newborns (see Warnings, Neonatal Sedation and …",[212],{"source":33,"section":213},"Pregnancy",{"level":206,"text":215,"quote":218,"refs":219},{"fa":216,"en":217},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Because of the varied response of pediatric patients to CNS-acting drugs, therapy should be initiated with the lowest dose and increased as required (see DOSAGE AND ADMINISTRATION ).",[220],{"source":33,"section":221},"Pediatric Use",{"kind":223,"refs":224,"id":191},"ANDA",[225],{"source":33,"section":226},"SPL approval \u002F marketing category",1792444712379]